Published in Cancer Weekly, March 2nd, 1998
Primary human pancreatic tumors were subcutaneously implanted in nude mice and then treated with a single intratumoral injection of bleomycin followed ten minutes later by electrical pulsing. The objective response at day 28 was 88% - complete response 68% and 20% partial response (more than 80% reduction in tumor volume).
In contrast, tumor volumes of the animals in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.